Initiating Clinical Trials

A Case Study of Breast Cancer Treatment

by Bruce J. Hillman, James P. Kahan

Purchase Print Copy

 FormatList Price Price
Add to Cart Paperback41 pages $23.00 $18.40 20% Web Discount

This Note describes and analyzes the events and considerations resulting in the initiation by the National Cancer Institute (NCI) and the National Surgical Adjuvant Breast and Bowel Project (NSABP) of the B-06 trial of breast-preserving surgery for breast cancer. The B-06 trial is a three-arm trial comparing the relative efficacy of total mastectomy vs. segmental mastectomy (lumpectomy) with and without radiation as treatment for stages I and II breast cancer. This Note largely details the period from 1975-1977, when the protocol was being designed and considered. The literature pertinent to the B-06 trial and interviews with individuals involved in the initiation decision and in operations of the NCI and NSABP describe several influences germane to the initiation of the trial: (1) the progress of the biological and clinical sciences; (2) the funding mechanism and administrative history of the trial and the relationship between NCI and the NSABP; (3) influential individuals; (4) the concerns of participating physicians and ethical issues pertinent to the trial; and (5) the potential effect of the trial on physicians' practices and patients' behavior.

This report is part of the RAND Corporation Note series. The note was a product of the RAND Corporation from 1979 to 1993 that reported other outputs of sponsored research for general distribution.

Our mission to help improve policy and decisionmaking through research and analysis is enabled through our core values of quality and objectivity and our unwavering commitment to the highest level of integrity and ethical behavior. To help ensure our research and analysis are rigorous, objective, and nonpartisan, we subject our research publications to a robust and exacting quality-assurance process; avoid both the appearance and reality of financial and other conflicts of interest through staff training, project screening, and a policy of mandatory disclosure; and pursue transparency in our research engagements through our commitment to the open publication of our research findings and recommendations, disclosure of the source of funding of published research, and policies to ensure intellectual independence. For more information, visit

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.